Aurinia Pharmaceuticals Inc. (AUPH) vs Azenta, Inc. (AZTA)

A side-by-side comparison of Aurinia Pharmaceuticals Inc. and Azenta, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AUPH vs AZTA

growth of $100 · dividends reinvested · last 10y
AUPH +288.1% (+14.5%/yr)AZTA +234.8% (+12.8%/yr)AUPH compounded faster over this window
02004006008001kStart $10020182020202220242026$388$335
AUPH AZTA

AUPH vs AZTA: by the numbers

  • •AZTA is the larger company ($2.05B vs $2.02B market cap).
  • •AUPH is profitable (100.84% net margin) while AZTA runs a net loss (-20.02%).
  • •AUPH grew revenue faster over the past five years (40.17% vs 4.82% CAGR).

Metrics side by side

Valuation

MetricAUPHAZTA
P/E ratio6.87N/A
Forward P/E16.6689.38
P/S ratio6.493.33
P/B ratio3.291.35
EV / EBITDA11.1955.80
FCF yield8.58%0.48%

Profitability

MetricAUPHAZTA
Gross margin90.36%44.05%
Operating margin37.06%-3.49%
Net margin100.84%-20.02%
ROE51.09%-8.14%
ROIC21.77%-1.33%

Growth (annualized)

MetricAUPHAZTA
Revenue CAGR (5Y)40.17%4.82%
Total return CAGR (5Y)-5.88%-15.91%

Frequently asked

Which has grown faster, AUPH or AZTA?
Over the past five years, AUPH grew revenue faster — AUPH at a 40.17% CAGR versus AZTA at 4.82%.
Is AUPH or AZTA more profitable?
AUPH runs the higher net margin — AUPH at 100.84% versus AZTA at -20.02%.
How have AUPH and AZTA total returns compared?
Over the past 10 years, AUPH delivered 14.53% and AZTA delivered 12.81% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.